Mechanism uncovered could also help preserve neuron function in Alzheimer’s disease, traumatic brain injury and other neurodegenerative conditions
Research presented by Dr. Lynn Raymond, from the University of British Columbia, shows that blocking a specific class of glutamate receptors, called extrasynaptic NMDA receptors, can improve motor learning and coordination, and prevent cell death in animal models of Huntington disease. As Huntington disease is an inherited condition that can be detected decades before any clinical symptoms are seen in humans, a better understanding of the earliest changes in brain cell (neuronal) function, and the molecular pathways underlying those changes, could lead to preventive treatments that delay the onset of symptoms and neurodegeneration. “After more than a decade of research on the pre-symptomatic phase of Huntington disease, markers are being developed to facilitate assessment of interventional therapy in individuals carrying the genetic mutation for Huntington disease, before they become ill. This will make it possible to delay onset of disease,” says Dr. Raymond.
Read more . . .
The Latest on: Huntington’s disease
[google_news title=”” keyword=”Huntington’s disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Huntington’s disease
- Huntington's Disease Warning Signs: What To Look Out Foron May 10, 2024 at 2:28 pm
Overview A condition that leads to progressive degeneration of nerve cells in the brain that affects movement, cognitive functions, and emotions. Symptoms If you or someone you know is exhibiting ...
- Buy Rating Affirmed for uniQure Amid Strong Pipeline and Regulatory Progresson May 9, 2024 at 10:16 pm
Analyst Joseph Schwartz from Leerink Partners reiterated a Buy rating on uniQure (QURE – Research Report) and decreased the price target ...
- Alzheimer's Newson May 9, 2024 at 4:59 pm
A Blood Test for Stroke Risk? Biomarker for Risk of Future Cerebrovascular Disease May 1, 2024 — A simple blood test could allow doctors to determine whether a person may be at higher risk for ...
- A year on, Teva CEO Richard Francis celebrates progress in 'Pivot to Growth' planon May 8, 2024 at 12:02 pm
In about a year after launching a revamp strategy under CEO Richard Francis, Teva has managed to return its generics business to growth, secure approvals for a pair of high-profile biosimilars | While ...
- Join the 3rd Annual Golf for a Cure for Huntington’s Diseaseon May 8, 2024 at 10:21 am
The Massachusetts and Rhode Island Chapters of the Huntington’s Disease Society of America want you to help find a cure by joining this year’s golf for a cure ...
- Teva Pharm Q1 profit misses estimates, revenue riseaon May 8, 2024 at 8:10 am
Teva Pharmaceutical Industries reported a smaller than expected rise in first-quarter profit citing higher impairments of tangible assets, while sales of copycat medicines and its branded drugs to ...
- Research suggests tear fluid testing as promising method for Huntington’s Disease monitoringon May 7, 2024 at 2:15 pm
Huntington's disease (HD) is an autosomal-dominant, fully-penetrant, neurodegenerative disease that most commonly affects adults during middle age.
- Huntington’s Disease Treatment Market Value: Understanding Pricing and Valuation Trendson May 6, 2024 at 11:24 pm
The global Huntington?s disease treatment market revenue was around US$ 316.5 million in 2021 and is estimated to reach US$ 708.2 million by 2031, growing at a compound annual growth rate (CAGR) of ...
- Team Hope Walk raises awareness for Huntington’s Diseaseon May 5, 2024 at 1:54 am
Saturday for the Team Hope Statewide Walk. The walk was to raise money for Huntington’s Disease. Huntington’s disease is a rare, neurodegenerative disease that causes nerve cells in the brain to ...
- Leprosy drug may be effective in Huntington's disease, study suggestson May 3, 2024 at 6:16 am
A preclinical study from Karolinska Institutet offers hope for treating severe neurodegenerative diseases with an existing drug. The study suggests that the leprosy drug clofazimine may be effective ...
via Bing News